Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism JAK2 inhibitors(Tyrosine-protein kinase JAK2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hemic and Lymphatic Diseases | Discovery | - | 30 May 2025 | |
Hemic and Lymphatic Diseases | Discovery | - | 30 May 2025 | |
Hepatitis | Discovery | - | 30 May 2025 | |
Hepatitis | Discovery | - | 30 May 2025 | |
Infectious Diseases | Discovery | - | 30 May 2025 | |
Infectious Diseases | Discovery | - | 30 May 2025 | |
Neoplasms | Discovery | - | 30 May 2025 | |
Neoplasms | Discovery | - | 30 May 2025 | |
Other Diseases | Discovery | - | 30 May 2025 | |
Other Diseases | Discovery | - | 30 May 2025 |